176 related articles for article (PubMed ID: 20183447)
1. An urn model for odds-ratio-based response-adaptive phase III clinical trials for two or more treatments.
Basak GK; Biswas A; Volkov S
J Biopharm Stat; 2009 Sep; 19(5):838-56. PubMed ID: 20183447
[TBL] [Abstract][Full Text] [Related]
2. A covariate adjusted two-stage allocation design for binary responses in randomized clinical trials.
Bandyopadhyay U; Biswas A; Bhattacharya R
Stat Med; 2007 Oct; 26(24):4386-99. PubMed ID: 17348082
[TBL] [Abstract][Full Text] [Related]
3. Covariate-adjusted adaptive designs for continuous responses in a phase III clinical trial: recommendation for practice.
Biswas A; Huang HH; Huang WT
J Biopharm Stat; 2006; 16(2):227-39. PubMed ID: 16584069
[TBL] [Abstract][Full Text] [Related]
4. A comparison of adaptive allocation rules for group-sequential binary response clinical trials.
Morgan CC; Stephen Coad D
Stat Med; 2007 Apr; 26(9):1937-54. PubMed ID: 16981177
[TBL] [Abstract][Full Text] [Related]
5. Optimal response-adaptive randomized designs for multi-armed survival trials.
Sverdlov O; Tymofyeyev Y; Wong WK
Stat Med; 2011 Oct; 30(24):2890-910. PubMed ID: 21823146
[TBL] [Abstract][Full Text] [Related]
6. Adaptive methods: telling "the rest of the story".
Emerson SS; Fleming TR
J Biopharm Stat; 2010 Nov; 20(6):1150-65. PubMed ID: 21058111
[TBL] [Abstract][Full Text] [Related]
7. Sequential urn designs with elimination for comparing K > or =3 treatments.
Coad DS; Ivanova A
Stat Med; 2005 Jul; 24(13):1995-2009. PubMed ID: 15803441
[TBL] [Abstract][Full Text] [Related]
8. Adaptive biased-coin designs for skewing the allocation proportion in clinical trials with normal responses.
Atkinson AC; Biswas A
Stat Med; 2005 Aug; 24(16):2477-92. PubMed ID: 16007571
[TBL] [Abstract][Full Text] [Related]
9. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW
Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718
[TBL] [Abstract][Full Text] [Related]
10. Covariate-adjusted response-adaptive designs for binary response.
Rosenberger WF; Vidyashankar AN; Agarwal DK
J Biopharm Stat; 2001 Nov; 11(4):227-36. PubMed ID: 12018777
[TBL] [Abstract][Full Text] [Related]
11. Bayesian adaptive biased-coin designs for clinical trials with normal responses.
Atkinson AC; Biswas A
Biometrics; 2005 Mar; 61(1):118-25. PubMed ID: 15737084
[TBL] [Abstract][Full Text] [Related]
12. The enrichment window approach as a means of dealing with placebo response in antidepressant clinical trials.
Mallinckrodt CH; Prucka WR
Clin Pharmacol Ther; 2010 Nov; 88(5):592-4. PubMed ID: 20959845
[TBL] [Abstract][Full Text] [Related]
13. Flexible design of two-stage adaptive procedures for phase III clinical trials.
Koyama T
Contemp Clin Trials; 2007 Jul; 28(4):500-13. PubMed ID: 17307399
[TBL] [Abstract][Full Text] [Related]
14. Test homogeneity of odds ratio in a randomized clinical trial with noncompliance.
Lui KJ; Chang KC
J Biopharm Stat; 2009 Sep; 19(5):916-32. PubMed ID: 20183452
[TBL] [Abstract][Full Text] [Related]
15. A flexible design for multiple armed screening trials.
Sargent DJ; Goldberg RM
Stat Med; 2001 Apr; 20(7):1051-60. PubMed ID: 11276035
[TBL] [Abstract][Full Text] [Related]
16. A seamless phase II/III design with sample-size re-estimation.
Bischoff W; Miller F
J Biopharm Stat; 2009 Jul; 19(4):595-609. PubMed ID: 20183428
[TBL] [Abstract][Full Text] [Related]
17. Targeting population entering phase III trials: a new stratified adaptive phase II design.
Tournoux-Facon C; De Rycke Y; Tubert-Bitter P
Stat Med; 2011 Apr; 30(8):801-11. PubMed ID: 21432875
[TBL] [Abstract][Full Text] [Related]
18. Covariate-adjusted response-adaptive designs for longitudinal treatment responses: PEMF trial revisited.
Biswas A; Park E; Bhattacharya R
Stat Methods Med Res; 2012 Aug; 21(4):379-92. PubMed ID: 20974667
[TBL] [Abstract][Full Text] [Related]
19. Adaptive designs for binary treatment responses in phase III clinical trials: controversies and progress.
Biswas A
Stat Methods Med Res; 2001 Oct; 10(5):353-64. PubMed ID: 11697227
[TBL] [Abstract][Full Text] [Related]
20. Meta-analyses and adaptive group sequential designs in the clinical development process.
Jennison C; Turnbull BW
J Biopharm Stat; 2005; 15(4):537-58. PubMed ID: 16022162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
